+

WO2001090117A3 - Haplotypes du gene p2ry1 - Google Patents

Haplotypes du gene p2ry1 Download PDF

Info

Publication number
WO2001090117A3
WO2001090117A3 PCT/US2001/016432 US0116432W WO0190117A3 WO 2001090117 A3 WO2001090117 A3 WO 2001090117A3 US 0116432 W US0116432 W US 0116432W WO 0190117 A3 WO0190117 A3 WO 0190117A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
p2ry1
gene
disclosed
p2ry1 gene
Prior art date
Application number
PCT/US2001/016432
Other languages
English (en)
Other versions
WO2001090117A2 (fr
Inventor
Amir Kazemi
Beena Koshy
Debra A Tanguay
Original Assignee
Genaissance Pharmaceuticals
Amir Kazemi
Beena Koshy
Debra A Tanguay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Amir Kazemi, Beena Koshy, Debra A Tanguay filed Critical Genaissance Pharmaceuticals
Priority to AU2001264767A priority Critical patent/AU2001264767A1/en
Publication of WO2001090117A2 publication Critical patent/WO2001090117A2/fr
Publication of WO2001090117A3 publication Critical patent/WO2001090117A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne des variants génétiques du gène du récepteur purinergique P2Y, couplé à la protéine G, 1 (P2RY1) ainsi que différents génotypes, haplotypes et paires d'haplotypes existant dans la population générale des Etats-Unis d'Amérique pour ce gène P2RY1. L'invention concerne également des compositions et des procédés pour l'haplotypage et/ou le génotypage du gène P2RY1 chez un individu. L'invention concerne enfin des polynucléotides définis par la séquence des haplotypes décrits.
PCT/US2001/016432 2000-05-19 2001-05-21 Haplotypes du gene p2ry1 WO2001090117A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001264767A AU2001264767A1 (en) 2000-05-19 2001-06-21 Haplotypes of the p2ry1 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20599600P 2000-05-19 2000-05-19
US60/205,996 2000-05-19

Publications (2)

Publication Number Publication Date
WO2001090117A2 WO2001090117A2 (fr) 2001-11-29
WO2001090117A3 true WO2001090117A3 (fr) 2002-04-18

Family

ID=22764547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016432 WO2001090117A2 (fr) 2000-05-19 2001-05-21 Haplotypes du gene p2ry1

Country Status (2)

Country Link
AU (1) AU2001264767A1 (fr)
WO (1) WO2001090117A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005101004A2 (fr) * 2004-04-13 2005-10-27 Bayer Healthcare Ag Diagnostics et therapeutiques pour des maladies associees au recepteur 1 de la purine de type y (p2y1)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 16 October 1998 (1998-10-16), LEON C.: "Direct submission", XP002907623, Database accession no. AJ006945 *
JANSSENS R. ET AL.: "Cloning and tissue distribution of the human P2Y1 receptor", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 221, 1996, pages 588 - 593, XP002907622 *
LEON C. ET AL.: "Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor", GENE, vol. 171, 1996, pages 295 - 297, XP004042812 *

Also Published As

Publication number Publication date
AU2001264767A1 (en) 2001-12-03
WO2001090117A2 (fr) 2001-11-29

Similar Documents

Publication Publication Date Title
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2001090117A3 (fr) Haplotypes du gene p2ry1
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2002006446A3 (fr) Haplotypes du gene edg6
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2001090124A3 (fr) Haplotypes du gene gpr31
WO2001079231A3 (fr) Haplotypes du gene npr1
WO2001096350A3 (fr) Haplotypes du gene grm3
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2001087905A3 (fr) Haplotypes du gene adora2a
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2001079238A3 (fr) Haplotypes du gene mmp3
WO2001075063A3 (fr) Haplotypes du gene chrnb3

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载